Imidazole compounds and their therapeutic applications

USRE37303E · kind E · reissue

Assignees

• Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
• BIOPROJET · FR

Inventors

• Jean-Charles Schwartz · Paris, FR
• Jean-Michel Arrang · Gif-sur-Yvette, FR
• Monique Garbarg · Paris, FR
• Jeanne-Marie Lecomte · Paris, FR
• Charon R. Ganellin · Welwyn Garden City, GB
• Abdellatif Fkyerat · La Bassée, FR
• Wasyl Tertiuk · Welwyn Garden City, GB
• Walter Schunack · Berlin, DE
• Ralph Lipp · Berlin, DE
• Holger Stark · Bad Homburg vor der Höhe, DE
• Katja Purand · Berlin, DE

Key dates

• Filing date: Apr 6, 2000
• Grant date: Jul 31, 2001
• Expiry date: Apr 6, 2020

Classification

• Technology area (CPC —): General

Abstract

A compound selected from the group consisting of a compound of the formula ##STR1## wherein the substituents are defined as in the specification having antagonist properties to histamine H.sub.3 -receptors.